Cargando…
Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1)
SIMPLE SUMMARY: Neurofibromatosis type 1 (Nf1) is a genetically determined neurodevelopmental disorder and tumor syndrome with an incidence of approximately 1/3000 live births. It is caused by loss of function mutations in the neurofibromin gene (Nf1) and is estimated to affect 100,000 people in the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526845/ https://www.ncbi.nlm.nih.gov/pubmed/37760547 http://dx.doi.org/10.3390/cancers15184579 |